Lasix Related Published Studies
Well-designed clinical trials related to Lasix (Furosemide)
Furosemide inhalation in dyspnea of mustard gas-exposed patients: a triple-blind randomized study. [2008.07]
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. [2008.07]
Impact of intravenous furosemide on flow rate characteristics and clinic waiting times. [2008.04]
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. [2008.02]
Inhaled furosemide does not alleviate respiratory effort during flow-limited exercise in healthy subjects. [2008]
Effect of inhaled furosemide on air hunger induced in healthy humans. [2007.04.16]
NXY-059 does not significantly interact with furosemide in healthy volunteers. [2006.12]
The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. [2006.11.29]
Topical furosemide versus oral steroid in preoperative management of nasal polyposis. [2006.08]
Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma. [2006.03]
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure. [2006]
Effect of magnesium and furosemide on bronchial asthma. [2005.11]
A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. [2005.08]
Efficacy of nebulized furosemide in children with moderate attack of asthma. [2005.07]
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. [2005.06.21]
The effect of furosemide infusion on serum epidermal growth factor concentration after acute lung injury. [2005.05]
Attenuation of the kaluretic properties of furosemide by triamterene (Dyrenium) in healthy volunteers. [2005.02]
A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. [2005.02]
Postpartum preeclampsia management with furosemide: a randomized clinical trial. [2005.01]
Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans. [2005]
Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients. [2005]
High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. [2004.09]
Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients. [2004.07]
Effects of furosemide and bendroflumethiazide on saliva flow rate and composition. [2004.07]
Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. [2004.05.01]
Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. [2004.04]
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life. [2003.12]
Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects. [2003.11]
Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. [2003.09]
Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers. [2003.09]
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. [2003.08]
Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers. [2003.07]
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. [2003.07]
The effect of inhaled furosemide and acetazolamide on bronchoconstriction induced by deep inspiration in asthma. [2003.04]
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. [2003.03]
Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. [2003.01]
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure. [2003.01]
In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations. [2003]
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. [2002.10]
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure. [2002.09.15]
Furosemide plus albuterol compared with albuterol alone in children with acute asthma. [2002.05]
Discontinuation of furosemide decreases PaCO(2) in patients with COPD. [2002.02]
Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. [2002.01]
Comparison of the efficacy of continuous furosemide and low-dose dopamine infusion in preeclampsia/eclampsia-related oliguria in the immediate postpartum period. [2002]
Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans. [2002]
Omapatrilat: neurohormonal and pharmacodynamic profile when administered with furosemide. [2001.12]
Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. [2001.11]
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. [2001.11]
Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. [2001.09]
Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome? [2001.08]
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. [2001.04]
Endogenous bradykinin and the renin and pressor responses to furosemide in humans. [2000.11]
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. [2000.09]
[Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure] [2000.08]
Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. [2000.06]
Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. [2000.06]
Healthcare costs of patients with heart failure treated with torasemide or furosemide. [2000.05]
Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. [2000.02]
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. [2000.01]
Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. [2000.01]
Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. [1999.09]
Furosemide in indomethacin-treated infants--systematic review and meta-analysis. [1999.04]
Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn. [1999.03]
Coadministration of albumin and furosemide in patients with the nephrotic syndrome. [1999.02]
Treatment of heartwater: potential adverse effects of furosemide administration on certain homeostatic parameters in normal sheep. [1998.12]
Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. [1998.12]
Usefulness of losartan, captopril, and furosemide in preventing nitrate tolerance and improving control of unstable angina pectoris. [1998.11.01]
Dose-dependent evaluation of the effects of nebulized furosemide on pulmonary function in ventilated preterm infants. [1998.09]
Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study. [1998.07.13]
A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report. [1998.07]
Coadministration of theophylline enhances diuretic response to furosemide in infants during extracorporeal membrane oxygenation: a randomized controlled pilot study. [1998.07]
Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients. [1998.03]
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. [1998.02.07]
Comparison of 6-hour infusion versus bolus furosemide in premature infants. [1998.01]
Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. [1998]
Effect of inhaled furosemide in acute asthma. [1998]
Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. [1997.12]
Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. [1997.10]
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. [1997.08]
Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. [1997.08]
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. [1997.07]
Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. [1997.06]
Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations. [1997.04]
Comparative study of inhaled amiloride and inhaled furosemide in exercise-induced asthma. [1997.03]
[Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients] [1997.03]
Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects. [1997.02]
Variable furosemide absorption and poor predictability of response in elderly patients. [1997.01]
Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. [1997.01]
Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide. [1997]
Furosemide given by inhalation ameliorates acute exacerbation of asthma. [1997]
Comparison of diuretic effects of glycerol with furosemide after transurethral prostatectomy. [1996.12]
Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs. [1996.12]
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. [1996.10]
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. [1996.08]
A simple prognostic index for patients with acute renal failure requiring dialysis. French Multicentric Prospective Study on Furosemide in Acute Renal Failure Requiring Dialysis. [1996.07]
Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. [1996.07]
Formulation and in vitro examination of furosemide containing suppositories and preliminary experiences of their clinical use. [1996.02]
Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters. [1996]
The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children. [1995.12]
Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. [1995.12]
Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. [1995.09]
|
